PDX model details
PDX ID
407M
Host Strain(and Source)
NSG Source: Monash University
Host Strain Immune system Humanized
NO
Host Type
Testosterone supplemented
Graft Site
Subcutaneous
Current Generation (* indicates number of generations grown in Castrate host)
9
Average PDX Generation Time (days +/- SEM)
73 ± 6
Tumor preparation
Tumor solid
Tumor Characterization Technology
Histology, IHC, STR profiling, targeted DNA sequencing, RNAseq
Tumor confirmed not to be of Mouse/EBV origin
Yes; negative for CD45 and/or positive for human CK8/18 and/or human mitochondria by IHC
Passage QA performed
Routine QA every 2-3 passages
Associated meta data
PDX model availability
Yes (fixed, frozen)
Governance restriction for distribution
Available to investigators with appropriate ethics approvals, approved EOI from MURAL committee, and material transfer agreements
Pubmed ID
34413304
Markers
407M
AR
Y
PSA
Y
PSMA
Y
NE
N
ERG
N
This heatmap displays the call type of curated CNVs in the presented samples.
This heatmap displays the call type of CNVs in commonly occurred samples.
This table displays curated CNVs
PDX ID
Gene Symbol
CNV Log2
CNV Copy
CNV Call
Experiments name
Platform
Reference genome
407M
RB1
-1.92501
0.526677
loss
MURAL Prostate Cancer PDX collection
Targeted Twist Panel
hg19
407M
SETD2
-0.843944
1.11424
loss
MURAL Prostate Cancer PDX collection
Targeted Twist Panel
hg19
407M
CHD1
-0.833774
1.12212
loss
MURAL Prostate Cancer PDX collection
Targeted Twist Panel
hg19
407M
APC
-0.833774
1.12212
loss
MURAL Prostate Cancer PDX collection
Targeted Twist Panel
hg19
407M
TP53
-0.82209
1.13124
loss
MURAL Prostate Cancer PDX collection
Targeted Twist Panel
hg19
407M
NCOR1
-0.82209
1.13124
loss
MURAL Prostate Cancer PDX collection
Targeted Twist Panel
hg19
407M
SMAD2
-0.779661
1.16501
loss
MURAL Prostate Cancer PDX collection
Targeted Twist Panel
hg19
407M
MBD1
-0.779661
1.16501
loss
MURAL Prostate Cancer PDX collection
Targeted Twist Panel
hg19
407M
JAK1
-0.771586
1.17155
loss
MURAL Prostate Cancer PDX collection
Targeted Twist Panel
hg19
407M
GEMIN5
0.781684
3.43827
gain
MURAL Prostate Cancer PDX collection
Targeted Twist Panel
hg19
407M
AKT1
0.908648
3.75457
gain
MURAL Prostate Cancer PDX collection
Targeted Twist Panel
hg19
407M
MYC
1.59361
6.03607
gain
MURAL Prostate Cancer PDX collection
Targeted Twist Panel
hg19
407M
CHD7
1.68431
6.42773
gain
MURAL Prostate Cancer PDX collection
Targeted Twist Panel
hg19
Clinical Information
Sample Number
407M
Sample Site
Liver
Sample source
Biopsy
Pathology Tumor Diagnosis
None
Gleason Score
None
Primary Gleason Score
None
Secondary Gleason Score
None
Tertiary Gleason Score
None
ISUP Grade Group
Tumor Grade
D'Amico Risk Classification
Tumor Volume (in cc)
0.0
Treatment Prior to Specimen Collection
ADT, docetaxel, abiraterone, enzalutamide
Patient Information
Patient Number
407
Sex
Male
Diagnosis
Prostate Cancer
PSA at diagnosis (ng/mL)
NA
Consent to share data
This heatmap displays the mutations of curated sequence variants.
Download
This table displays curated sequence variants
The table can be sorted by any field. However, please note that when you click on a column header to sort, there might be a brief delay
PDX ID
Gene Symbol
Depth
ALT_FREQ
Consequence
Exon
GnomAD_AF
CADD_PHRED
Clinvar_clnsig
Platform
Experiments Name
Reference
Library Type
Instrument Type
407M
TP53
249
1.0
stop_gained
'4/11
.
35
-
Targeted Twist Panel
MURAL Prostate Cancer PDX collection
hg19
paired
NextSeq 500
407M
SMAD2
199
0.98
stop_gained
'11/11
.
42
-
Targeted Twist Panel
MURAL Prostate Cancer PDX collection
hg19
paired
NextSeq 500
407M
APC
206
0.93
frameshift_variant
'16/16
.
.
-
Targeted Twist Panel
MURAL Prostate Cancer PDX collection
hg19
paired
NextSeq 500
407M
AKT1
552
0.64
missense_variant,splice_region_variant
'2/13
4.08E-06
25.9
Pathogenic/Likely_pathogenic
Targeted Twist Panel
MURAL Prostate Cancer PDX collection
hg19
paired
NextSeq 500
407M
CACNA1H
347
0.54
missense_variant
'10/35
0.0002622
4.878
-
Targeted Twist Panel
MURAL Prostate Cancer PDX collection
hg19
paired
NextSeq 500
407M
NF1
286
0.49
missense_variant
'51/58
0.0007889
25.4
Conflicting_interpretations_of_pathogenicity
Targeted Twist Panel
MURAL Prostate Cancer PDX collection
hg19
paired
NextSeq 500
407M
MAST4
522
0.48
missense_variant
'2/29
0.0008207
33
-
Targeted Twist Panel
MURAL Prostate Cancer PDX collection
hg19
paired
NextSeq 500
407M
NOTCH3
406
0.32
missense_variant
'6/33
0.0003093
24.7
-
Targeted Twist Panel
MURAL Prostate Cancer PDX collection
hg19
paired
NextSeq 500
No information in Drug dosing Table